Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6838-6845

  Ibrahim, El Chérif ^a   Guerra, Nadia ^b   Lacombe, Marie José Terrier ^b   Angevin, Eric ^b   Chouaib, Salem ^b   Carosella, Edgardo D ^a   Caignard, Anne ^b   Paul, Pascale ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CARCINOMA; MALE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; TUMOR IMMUNITY;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERONS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035884692     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Recombinant human interleukin-2, recombinant human interferon α-2a, or both in metastatic renal-cell carcinoma
2. lck in T-cell infiltrating human renal cell carcinoma
3. Mechanisms of apoptosis in T cells from patients with renal cell carcinoma
4. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas
5. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma
6. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes
7. Renal cell carcinomas produce IL-6, IL-10, IL-11, and TGF-β 1 in primary cultures and modulate T lymphocyte blast transformation
8. Renal cell carcinoma derived gangliosides suppress nuclear factor-κB activation in T cells
9. 2 production by monocytes
10. Escape of human solid tumours from T-cell recognition: Molecular mechanisms and functional significance
11. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection
12. HLA-G, and -E, fundamental and patophysiological aspects
13. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens
14. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
15. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells
16. The functionality of HLA-G is emerging
17. A class I antigen. HLA-G, expressed in human trophoblasts
18. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
19. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
20. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA-G) bind to peripheral blood myelomonocytic cells
21. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
22. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
23. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
24. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor
25. Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8
26. Paired inhibitory and triggering NK cell receptors for HLA class I molecules
27. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines
28. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
29. HLA-G inhibits the transendothelial migration of human NK cells
30. Distribution of human class I (HLA-A, B, C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin
31. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon γ
32. Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma
33. Expression of the human nephron differentiation molecules in renal cell carcinomas
34. Expression of HLA-A, B, C antigens on primary and metastatic tumor cell populations of human carcinomas
35. Immunohistochemical detection of major hisocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer
36. Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinoma
37. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: Correlation with clinical and histopathological data
38. Characteristics of MHC antigen expression and tumor-infiltrating mononuclear cells in renal cell adenomas and carcinomas
39. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
40. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation
41. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules
42. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products
43. 2-microglobulin-free HLA class I heavy chains
44. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies
45. Comparaison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes
46. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines
47. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
48. Expression analysis of classic and non-classic HLA molecules before interferon α-2b treatment of melanoma
49. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
50. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
51. Expression of HLA-G in human tumors is not a frequent event
52. HLA-G protein expression is not induced during malignant transformation
53. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by γIFN treatment
54. Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys
55. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors
56. Expression of class I and II major histocompatibility complex antigens in Wilms’ tumour and normal developing human kidney
57. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
58. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ
59. Soluble HLA-G in human placentas: Synthesis in trophoblasts and interferon-γ-activated macrophages but not placental fibroblasts
60. Aberrant expression of HLA-G antigen in interferon γ-stimulated acute myelogenous leukaemia
61. Modulation of HLA-G expression in human thymic and amniotic epithelial cells
62. Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: The ISRE-mediated route and a novel pathway involving CIITA
63. A specific ISRE of the distal HLA-G promoter binds IRF-1 and mediates enhancemcnt of this nonclassical histocompatiblity class I gene by IFN-β
64. Cloned human interferon-γ, but no interferon-β or -α, induces expression of HLA-DR determinants by fetal monocytes and myeloid cell lines
65. HLA-G2, -G3, and -G4 isoforms expressed as non mature cell-surface glycoproteins inhibit NK and antigen-specific CTL cytolysis